Metaphore Biotechnologies

Metaphore Biotechnologies

生物技术研究

Unlocking the therapeutic potential of biomimicry

关于我们

Metaphore Biotechnologies is harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics. The company’s MIMiC? platform is a computationally driven bioplatform designing new therapeutics where function, specificity, and selectivity can be optimized. Metaphore is focused on making previously intractable drug targets accessible and unlocking breakthroughs that outperform today’s drugs for maximum patient impact. Metaphore was founded in 2021 in Flagship Labs, a unit of Flagship Pioneering.

网站
https://metaphorebio.com/
所属行业
生物技术研究
规模
11-50 人
类型
私人持股

Metaphore Biotechnologies员工

动态

相似主页

融资